AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has announced a partnership with Arizona State University (ASU)for the development of a COVID-19 “Correlate of protection” through the company’s rapid...
AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has announced the publication of an article in the Journal of Clinical Virology detailing the development of a rapid COVID-19 neutralizing...
Affinor Growers Inc. (OTCMKTS: RSSFF) has appointed Ben Hogervorst to its Advisory Board to help it in business execution and its five-year growth strategy domestically and...
Axim Biotechnologies Inc. (OTCMKTS: AXIM) has appointed Kelly K Nichols to its Medical Advisory Board. Nichols joins the company’s other Advisory Board members, including Laura Periman,...
Axim Biotechnologies Inc (OTCMKTS: AXIM) has appointed a new member to its Medical Advisory Board. Henry D. Perry, M.D, the appointee, is the third member hired...
Axim Biotechnologies Inc (OTCMKTS: AXIM) has announced that it has created a second-generation Rapid Antibody Neutralizing Test for COVID-19. The test is known as ImmunoPass. T...
Axim Biotechnologies Inc (OTCMKTS: AXIM) is at the helm of affairs. The group recently announced that it had included Dr. Laura Periman in its Medical Advisory...
Dry Eye Disease (DED) affects more than 344 million people worldwide, and the number is growing in both young and old adults. Hence, clinicians have found...
AXIM Biotechnologies Inc. (OTCMKTS: AXIM) has finalized pre-clinical drug studies on the patent waiting for compound SPX-1009, showing malignant metastatic melanoma cells suppression. Dr. Douglas Lake’s...